Evaluation of MTHFR677CT< polymorphism in prediction and prognosis of esophageal squamous cell carcinoma: A case-control study in a Northern Indian population

Nutrition and Cancer

Volumn 62, Issue 6, 2010, Pages 743-749

  Umar, Meenakshi ^a   Upadhyay, Rohit ^a   Khurana, Rohini ^a   Kumar, Shaleen ^a   Ghoshal, Uday Chand ^a   Mittal, Balraj ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2);

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER CHEMOTHERAPY; CANCER EPIDEMIOLOGY; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURVIVAL; CASE CONTROL STUDY; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; FOLLOW UP; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; RISK FACTOR; SMOKING; AGED; ESOPHAGUS TUMOR; GENETIC PREDISPOSITION; GENETICS; INDIA; MIDDLE AGED; MORTALITY; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; ESOPHAGEAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INDIA; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMORPHISM, GENETIC; PROGNOSIS;

EID: 77955004111     PISSN: 01635581     EISSN: None     Source Type: Journal    
DOI: 10.1080/01635581003605961     Document Type: Article

References (42)

1. Hiyama T, Yoshihara M, Tanaka S, and Chayama K: Genetic polymorphisms and esophageal cancer risk. Int J Cancer 121, 1643-1658, 2007.
2. McCabe ML and Dlamini Z: The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5, 1113-1130, 2005.
3. Lu SH, Chui SX, Yang WX, Hu XN, Guo LP, et al.: Relevance of N- nitrosamines to oesophageal cancer in China. IARC Sci Publ 105, 11-17, 1991.
4. Yoshizawa T, Yamashita A, and Luo Y: Fumonisin occurrence in corn from high- and low-risk areas for human esophageal cancer in China. Appl Environ Microbiol 60, 1626-1629, 1994.
5. Cheng KK and Day NE: Nutrition and esophageal cancer. Cancer Causes Control 7, 33-40, 1996.
6. Gallus S and La Vecchia C: Is there a link between diet and esophageal cancer? Nat Clin Pract Gastroenterol Hepatol 4, 2-3, 2007.
7. Giovannucci E, Rimm EB, Ascherio A, Stampfer MJ, Colditz GA, et al.: Alcohol, low-methionine-low-folate diets, and risk of colon cancer in men. J Natl Cancer Inst 87, 265-273, 1995.
8. Tseng M, Murray SC, Kupper LL, and Sandler RS: Micronutrients and the risk of colorectal adenomas. Am J Epidemiol 144, 1005-1014, 1996.
9. Jaskiewicz K, Marasas WF, Lazarus C, Beyers AD, and Van Helden PD: Association of esophageal cytological abnormalities with vitamin and lipotrope deficiencies in populations at risk for esophageal cancer. Anticancer Res 8, 711-715, 1988.
10. Prasad MP, Krishna TP, Pasricha S, Krishnaswamy K, and Quereshi MA: Esophageal cancer and diet-a case-control study. Nutr Cancer 18, 85-93, 1992.
11. Goyette P, Sumner JS, Milos R, Duncan AM, Rosenblatt DS, et al.: Human methylenetetrahydrofolate reductase: isolation of cDNA mapping and mutation identification. Nat Genet 7, 551, 1994.
12. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, et al.: A candidate genetic risk factor for vascular disease: a common mutation in methylenete- trahydrofolate reductase. Nat Genet 10, 111-113, 1995.
13. Dong LM, Potter JD, White E, Ulrich CM, Cardon LR, et al.: Genetic susceptibility to cancer: the role of polymorphisms in candidate genes. JAMA 299, 2423-2436, 2008.
14. Cao HX, Gao CM, Takezaki T, Wu JZ, Ding JH, et al.: Genetic polymorphisms of methylenetetrahydrofolate reductase and susceptibility to colorectal cancer. Asian Pac J Cancer Prev 9, 203-208, 2008.
15. Suzuki T, Matsuo K, Hasegawa Y, Hiraki A, Wakai K, et al.: One-carbon metabolism-related gene polymorphisms and risk of head and neck squamous cell carcinoma: case-control study. Cancer Sci 98, 1439-1446, 2007. (Pubitemid 47241768)
16. Suzuki T, Matsuo K, Hirose K, Hiraki A, Kawase T, et al.: One-carbon metabolism-related gene polymorphisms and risk of breast cancer. Carcinogenesis 29, 356-362, 2008.
17. Bai JL, Zheng MH, Xia X, Ter-Minassian M, Chen YP, et al.: MTHFR C677T polymorphism contributes to prostate cancer risk among Caucasians: a meta-analysis of 3511 cases and 2762 controls. Eur J Cancer 45, 1443-1449, 2009.
18. Boccia S, Boffetta P, Brennan P, Ricciardi G, Gianfagna F, et al.: Meta- analyses of the methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and risk of head and neck and lung cancer. Cancer Lett 273, 55-61, 2009.
19. Yu MC, Yuan JM, and Lu SC: Alcohol, cofactors, and the genetics of hepatocellular carcinoma. J Gastroenterol Hepatol 23(1 Suppl), S92-S97, 2008.
20. Zintzaras E: Methylenetetrahydrofolate reductase gene and susceptibility to breast cancer: a meta-analysis. Clin Genet 69, 327-336, 2006.
21. Larsson SC, Giovannucci E, and Wolk A: Folate intake, MTHFR polymorphisms, and risk of esophageal, gastric, and pancreatic cancer: a meta- analysis. Gastroenterology 131, 1271-1283, 2006.
22. Song C, Xing D, Tan W, Wei Q, and Lin D: Methylenetetrahydrofolate reductase polymorphisms increase risk of esophageal squamous cell carcinoma in a Chinese population. Cancer Res 61, 3272-3275, 2001.
23. Stolzenberg-Solomon RZ, Qiao YL, Abnet CC, Ratnasinghe DL, Dawsey SM, et al.: Esophageal and gastric cardia cancer risk and folate- and vitamin B(12)-related polymorphisms in Linxian, China. Cancer Epidemiol Biomarkers Prev 12, 1222-1226, 2003.
24. Yang CX, Matsuo K, Ito H, Shinoda M, Hatooka S, et al.: Gene-environment interactions between alcohol drinking and the MTHFR C677T polymorphism impact on esophageal cancer risk: results of a case-control study in Japan. Carcinogenesis 26, 1285-1290, 2005.
25. Upadhyay R, Jain M, Kumar S, Ghoshal UC, and Mittal B: Functional polymorphisms of cyclooxygenase-2 (COX-2) gene and risk for esophageal squamous cell carcinoma. Mutat Res 663, 52-59, 2009.
26. Upadhyay R, Jain M, Kumar S, Ghoshal UC, and Mittal B: Association of interleukin-6 (-174G
27. Jain M, Tilak AR, Upadhyay R, Kumar A, and Mittal B: Microsomal epoxide hydrolase (EPHX1), slow (exon 3, 113His) and fast (exon 4, 139Arg) alleles confer susceptibility to squamous cell esophageal cancer. Toxicol Appl Pharmacol 230, 247-251, 2008.
28. Miller SA, Dykes DD, and Polesky HF: A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16, 1215, 1988.
29. Shen H, Spitz MR, Wang LE, Hong WK, and Wei Q: Polymorphisms of methylene-tetrahydrofolate reductase and risk of lung cancer: a case-control study. Cancer Epidemiol Biomarkers Prev 10, 397-401, 2001.
30. Gauderman WJ MJ: QUANTO 1.1: A computer program for power and sample size calculations for genetic-epidemiology studies. 2006. Available from: http://hydrauscedu/gxe.
31. Wilcken B, Bamforth F, Li Z, Zhu H, Ritvanen A, et al.: Geographical and ethnic variation of the 677C
32. Reddy H and Jamil K: Polymorphisms in the MTHFR gene and their possible association with susceptibility to childhood acute lymphocytic leukemia in an Indian population. Leuk Lymphoma 47, 1333-1339, 2006.
33. Joshi G, Pradhan S, and Mittal B: Role of the ACE ID and MTHFR C677T polymorphisms in genetic susceptibility of migraine in a north Indian population. J Neurol Sci 277, 133-137, 2009.
34. Sarbia M, Stahl M, von Weyhern C, Weirich G, and Puhringer-Oppermann F: The prognostic significance of genetic polymorphisms (methylenete- trahydrofolate reductase C677T, methionine synthase A2756G, thymidi- late synthase tandem repeat polymorphism) in multimodally treated oesophageal squamous cell carcinoma. Br J Cancer 94, 203-207, 2006.
35. Wu X, Gu J, Wu TT, Swisher SG, Liao Z, et al.: Genetic variations in radiation and chemotherapy drug action pathways predict clinical outcomes in esophageal cancer. J Clin Oncol 24, 3789-3798, 2006.
36. Langevin SM, Lin D, Matsuo K, Gao CM, Takezaki T, et al.: Review and pooled analysis of studies on MTHFR C677T polymorphism and esophageal cancer. Toxicol Lett 184, 73-80, 2009.
37. Mayor-Olea A, Callejon G, Palomares AR, Jimenez AJ, Gaitan MJ, et al.: Human genetic selection on the MTHFR 677C< T polymorphism. BMC Med Genet 9, 104, 2008.
38. Srivastava A, Pandey SN, Pandey P, Choudhuri G, and Mittal B: No association of Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism in susceptibility to gallbladder cancer. DNA Cell Biol 27, 127-132, 2008.
39. Shekari M, Sobti RC, Kordi Tamandani DM, and Suri V: Impact of methylenetetrahydrofolate reductase (MTHFR) codon (677) and methionine synthase (MS) codon (2756) on risk of cervical carcinogenesis in North Indian population. Arch Gynecol Obstet 278, 517-524, 2008.
40. Kawabe A, Shimada Y, Uchida S, Maeda M, Sato F, et al.: Expression of cyclooxygenase-2 is associated with carcinogenesis of the lower part of thoracic esophageal squamous cell carcinoma and p53 expression. Oncology 62, 46-54, 2002.
41. Boccia S, Gianfagna F, Persiani R, La Greca A, Arzani D, et al.: Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and susceptibility to gastric adenocarcinoma in an Italian population. Biomarkers 12, 635-644, 2007.
42. Weinstein SJ, Gridley G, Harty LC, Diehl SR, Brown LM, et al.: Fo- late intake, serum homocysteine and methylenetetrahydrofolate reductase (MTHFR) C677T genotype are not associated with oral cancer risk in Puerto Rico. J Nutr 132, 762-767, 2002.